Skip to main content

The SCID-hu Myeloma Model

  • Protocol
Multiple Myeloma

Part of the book series: Methods in Molecular Medicineā„¢ ((MIMM,volume 113))

Abstract

The severe combined immune deficient human (SCID-hu) myeloma model is the only available model in which primary myeloma cells grow in vivo in a human bone marrow microenvironment. A SCID mouse receives an implanted human fetal bone into which myeloma cells are directly injected. Through interaction with the human bone marrow microenvironment, the myeloma cells induce typical myeloma manifestations in the SCID host, such as the appearance of M protein in the serum, and changes in the implanted human bone, which often result in osteolysis of the human bone. The model provides the only platform for in vivo investigation of the biology and therapy of primary human myeloma in a human microenvironment. This chapter describes in detail all the steps necessary to establish this model and evaluate its success.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kyoizumi S., Baum C. M., Kaneshima H., McCune J. M., Yee E. J., and Namikawa R. (1992) Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79, 1704ā€“1711.

    PubMedĀ  CASĀ  Google ScholarĀ 

  2. Yaccoby S., Pearse R. N., Johnson C. L., Barlogie B., Choi Y., and Epstein J. (2002) Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br. J. Haematol. 116, 278ā€“290.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  3. Pearse R. N., Sordillo E. M., Yaccoby S., et al. (2001) Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. USA 98, 11,581ā€“11,586.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  4. Yaccoby S. and Epstein J. (1999) The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood 94, 3576ā€“3582.

    PubMedĀ  CASĀ  Google ScholarĀ 

  5. Yaccoby S., Barlogie B., and Epstein J. (1998) Primary myeloma cells growing in SCID-hu miceā€”a model for studying the biology and treatment of myeloma and its manifestations. Blood 92, 2908ā€“2913.

    PubMedĀ  CASĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Epstein, J., Yaccoby, S. (2005). The SCID-hu Myeloma Model. In: Brown, R.D., Ho, P.J. (eds) Multiple Myeloma. Methods in Molecular Medicineā„¢, vol 113. Humana Press. https://doi.org/10.1385/1-59259-916-8:183

Download citation

  • DOI: https://doi.org/10.1385/1-59259-916-8:183

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-392-3

  • Online ISBN: 978-1-59259-916-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics